EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

STING trafficking as a new dimension of immune signaling

Devon Jeltema iD, Kennady Abbott iD, Nan Yan iD

Journal of Experimental Medicine · 06.03.2023 · 220 (3)

DOI: 10.1084/jem.20220990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 27.01.2023. Verfasst von Devon Jeltema und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, UT Southwestern Medical Center , Dallas, TX, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Membrane Proteins. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cGAS–STING pathway is an evolutionarily conserved immune signaling pathway critical for microbial defense. Unlike other innate immune pathways that largely rely on stationary cascades of signaling events, STING is highly mobile in the cell. STING is activated on the ER, but only signals after it arrives on the Golgi, and then it is quickly degraded by the lysosome. Each step of STING trafficking through the secretory pathway is regulated by host factors. Homeostatic STING trafficking via COPI-, COPII-, and clathrin-coated vesicles is important for maintaining baseline tissue and cellular immunity. Aberrant vesicular trafficking or lysosomal dysfunction produces an immune signal through STING, which often leads to tissue pathology in mice and humans. Many trafficking-mediated diseases of STING signaling appear to impact the central nervous system, leading to neurodegeneration. Therefore, STING trafficking introduces a new dimension of immune signaling that likely has broad implications in human disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateMembrane ProteinsAnimalsHumansMiceNucleotidyltransferasesSignal TransductionSTING Protein

Substanzen

Membrane ProteinsNucleotidyltransferasesSTING1 protein, humanSTING ProteinSting1 protein, mouse

Autor:innen und Institutionen

  • Department of Immunology, UT Southwestern Medical Center , Dallas, TX, USA.

ORCID-Profile: Devon Jeltema, Kennady Abbott, Nan Yan

Förderung

  • NIAID NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health
  • University of Texas Southwestern Immunology T32 training
  • Cancer Prevention and Research Institute of Texas
  • Grace Science Foundation
  • Ara Parseghian Medical Research Fund

Zitieren

APA

Jeltema, D., Abbott, K., & Yan, N. (2023). STING trafficking as a new dimension of immune signaling. Journal of Experimental Medicine, 220(3). https://doi.org/10.1084/jem.20220990

Vancouver

Jeltema D, Abbott K, Yan N. STING trafficking as a new dimension of immune signaling. Journal of Experimental Medicine. 2023;220(3). doi:10.1084/jem.20220990

BibTeX
@article{Jeltema2023,
  author = {Jeltema, Devon and Abbott, Kennady and Yan, Nan},
  title = {STING trafficking as a new dimension of immune signaling},
  journal = {Journal of Experimental Medicine},
  year = {2023},
  volume = {220},
  number = {3},
  doi = {10.1084/jem.20220990}
}
Kostenlos starten →